|
SE8004002L
(sv)
|
1980-05-29 |
1981-11-30 |
Arvidsson Folke Lars Erik |
Terapeutiskt anvendbara tetralinderivat
|
|
IL65501A
(en)
|
1981-05-08 |
1986-04-29 |
Astra Laekemedel Ab |
1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
|
|
DE3718317A1
(de)
|
1986-12-10 |
1988-06-16 |
Bayer Ag |
Substituierte basische 2-aminotetraline
|
|
DE3719924A1
(de)
|
1986-12-22 |
1988-06-30 |
Bayer Ag |
8-substituierte 2-aminotetraline
|
|
JP2785879B2
(ja)
|
1989-05-31 |
1998-08-13 |
ジ・アップジョン・カンパニー |
治療学的に有用な２―アミノテトラリン誘導体
|
|
FR2659853A1
(fr)
|
1990-03-22 |
1991-09-27 |
Midy Spa |
Utilisation de derives 2-aminotetraliniques pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale.
|
|
EP0738149B1
(en)
|
1994-01-10 |
2006-11-29 |
Teva Pharmaceutical Industries, Ltd. |
1-aminoindan derivatives and compositions thereof
|
|
AU765142B2
(en)
|
1998-06-01 |
2003-09-11 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method for treating neurodegenerative disorders
|
|
DE19834044A1
(de)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Neue substituierte Pyrazolderivate
|
|
DE19834047A1
(de)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Substituierte Pyrazolderivate
|
|
GB9827467D0
(en)
|
1998-12-15 |
1999-02-10 |
Zeneca Ltd |
Chemical compounds
|
|
DE19943635A1
(de)
|
1999-09-13 |
2001-03-15 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
|
AR031176A1
(es)
|
2000-11-22 |
2003-09-10 |
Bayer Ag |
Nuevos derivados de pirazolpiridina sustituidos con piridina
|
|
DE10109861A1
(de)
|
2001-03-01 |
2002-09-05 |
Bayer Ag |
Neuartige seitenkettenhalogenierte Aminodicarbonsäurederivate
|
|
DE10109859A1
(de)
|
2001-03-01 |
2002-09-05 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate
|
|
DE10109858A1
(de)
|
2001-03-01 |
2002-09-05 |
Bayer Ag |
Neuartige halogensubstituierte Aminodicarbonsäurederivate
|
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
|
DE10110749A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Substituierte Aminodicarbonsäurederivate
|
|
DE10220570A1
(de)
|
2002-05-08 |
2003-11-20 |
Bayer Ag |
Carbamat-substituierte Pyrazolopyridine
|
|
JP2006522634A
(ja)
|
2003-04-14 |
2006-10-05 |
ベクトゥラ・リミテッド |
投与効率を向上させるデバイス及び製薬組成
|
|
US20050032873A1
(en)
|
2003-07-30 |
2005-02-10 |
Wyeth |
3-Amino chroman and 2-amino tetralin derivatives
|
|
CN101146763A
(zh)
|
2005-03-30 |
2008-03-19 |
默克公司 |
胰高血糖素受体拮抗剂化合物、含有这种化合物的组合物以及使用方法
|
|
DE102005050377A1
(de)
|
2005-10-21 |
2007-04-26 |
Bayer Healthcare Ag |
Heterocyclische Verbindungen und ihre Verwendung
|
|
US20090048295A1
(en)
|
2007-08-13 |
2009-02-19 |
Joseph Kent Barbay |
Substituted 5,6,7,8-tetrahydroquinoline derivatives, compositions, and methods of use thereof
|
|
CN101939053A
(zh)
|
2007-09-06 |
2011-01-05 |
默沙东公司 |
可溶性的鸟苷酸环化酶活化剂
|
|
JP2011185957A
(ja)
|
2008-07-04 |
2011-09-22 |
Sharp Corp |
偏光板、表示装置及びその製造方法
|
|
US8653099B2
(en)
|
2008-08-19 |
2014-02-18 |
Janssen Pharmaceutica |
Cold menthol receptor antagonists
|
|
DE102010020553A1
(de)
|
2010-05-14 |
2011-11-17 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 8-Alkoxy-2-aminotetralin-Derivate und ihre Verwendung
|
|
DE102010021637A1
(de)
|
2010-05-26 |
2011-12-01 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung
|
|
CA2803688A1
(en)
|
2010-06-25 |
2011-12-29 |
Bayer Intellectual Property Gmbh |
Use of stimulators and activators of soluble guanylate cyclase for treating sickle-cell anemia and conserving blood substitutes
|
|
EP2590979A1
(de)
|
2010-07-09 |
2013-05-15 |
Bayer Intellectual Property GmbH |
Annellierte pyrimidine und triazine und ihre verwendung zur behandlung bzw. prophylaxe von herz-kreislauf-erkrankungen
|
|
DE102010040233A1
(de)
|
2010-09-03 |
2012-03-08 |
Bayer Schering Pharma Aktiengesellschaft |
Bicyclische Aza-Heterocyclen und ihre Verwendung
|
|
DE102010043379A1
(de)
|
2010-11-04 |
2012-05-10 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung
|
|
US8569339B2
(en)
|
2011-03-10 |
2013-10-29 |
Boehringer Ingelheim International Gmbh |
Soluble guanylate cyclase activators
|
|
BR112014002472A2
(pt)
|
2011-08-12 |
2017-04-11 |
Nissan Chemical Ind Ltd |
"compostos heterocíclicos tricíclicos, seu uso, agente terapêutico para reumatismo articular e medicamento"
|
|
RU2640416C2
(ru)
|
2012-04-16 |
2018-01-09 |
Тоа Эйо Лтд. |
Бициклическое соединение
|
|
PL2875003T3
(pl)
|
2012-07-20 |
2017-05-31 |
Bayer Pharma Aktiengesellschaft |
Nowe kwasy 5-aminotetrahydrochinolino-2-karboksylowe i ich zastosowanie
|
|
JP6324956B2
(ja)
|
2012-07-20 |
2018-05-16 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
置換アミノインダン−およびアミノテトラリンカルボン酸ならびにその使用
|
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
|
GB201305825D0
(en)
|
2013-03-28 |
2013-05-15 |
Vectura Ltd |
New use
|
|
WO2019081456A1
(en)
|
2017-10-24 |
2019-05-02 |
Bayer Aktiengesellschaft |
USE OF SGC ACTIVATORS AND STIMULATORS COMPRISING A BETA2 SUBUNIT
|
|
KR20230012494A
(ko)
|
2020-05-20 |
2023-01-26 |
바이엘 악티엔게젤샤프트 |
부틸 (5s)-5-(｛2-[4-(부톡시카르보닐)페닐]에틸｝[2-(2-｛[3-클로로-4'-(트리플루오로메틸)[비페닐]-4-일]메톡시｝페닐)에틸]아미노)-5,6,7,8-테트라히드로퀴놀린-2-카르복실레이트의 제조 방법
|
|
TW202342035A
(zh)
|
2021-12-29 |
2023-11-01 |
德商拜耳廠股份有限公司 |
醫藥乾粉吸入配製物
|
|
TW202342034A
(zh)
|
2021-12-29 |
2023-11-01 |
德商拜耳廠股份有限公司 |
心肺病症之治療
|
|
AU2022429647A1
(en)
|
2021-12-29 |
2024-07-04 |
Bayer Aktiengesellschaft |
Process for preparing (5s)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4- yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound
|